Junjun Y. Ni
The Key Laboratory Of Biomedical Information Engineering Of Ministry Of Education
Xi'an, 710049, China
Xi'an, 710049, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 87 publications
Nitric Oxide Conjugation Transforms NIR-II AIEgens Into Potent Hypoxia-Tolerant Type I Photosensitizers.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: January 18, 2026
Experience-Dependent Reorganization of Hippocampal CA3 Neuronal Ensembles Associates With Memory Generalization.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 12, 2026
Cathepsins in Ischemic Stroke: Unveiling Neuropharmacological Roles and Therapeutic Potential.
Journal: Current neuropharmacology
Published: May 12, 2025
Lipopolysaccharides from Porphyromonas gingivalis indirectly induce neuronal GSK3β-dependent synaptic defects and cause cognitive decline in a low-amyloid-β-concentration environment in Alzheimer's disease.
Journal: Journal of Alzheimer's disease : JAD
Published: March 20, 2025
NIR-II AIEgen with high photothermal efficiency for mild PTT: Optimized natural killer cell spatial distribution for boosted immune response.
Journal: Biomaterials
Published: March 01, 2025
The medial septum-hippocampus-lateral septum circuitry in spatial memory: linking healthy function to early Alzheimer's disease and translational opportunities.
Journal: Translational neurodegeneration
Published: February 19, 2025
Cathepsin B deficiency disrupts cortical development via PEG3, leading to depression-like behavior.
Journal: Communications biology
Published: February 17, 2025
The dynamic impairment of synaptic transmission in the PCx-IL engram circuit contributes to early olfactory memory decline in Alzheimer's disease.
Journal: Molecular psychiatry
Published: February 12, 2025
Targeted delivery of BACE1 siRNA for synergistic treatment of Alzheimer's disease.
Journal: Translational neurodegeneration
Published: January 14, 2025
Machine-learning based strategy identifies a robust protein biomarker panel for Alzheimer's disease in cerebrospinal fluid.
Journal: Alzheimer's research & therapy
Published: January 08, 2025
Last Updated: 09/26/2026